Michael Heike

5.7k total citations
58 papers, 1.6k citations indexed

About

Michael Heike is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology. According to data from OpenAlex, Michael Heike has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 19 papers in Immunology and 18 papers in Oncology. Recurrent topics in Michael Heike's work include Immunotherapy and Immune Responses (17 papers), Gastric Cancer Management and Outcomes (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). Michael Heike is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Gastric Cancer Management and Outcomes (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). Michael Heike collaborates with scholars based in Germany, United States and France. Michael Heike's co-authors include Peter R. Galle, Pramod K. Srivastava, K-H MEYER ZUM BÜSCHENFELDE, Rainer Duchmann, Ekkehard May, Percy A. Knolle, Markus F. Neurath, Markus Moehler, M Sandmann and Alexander Knuth and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Michael Heike

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Heike Germany 19 700 542 451 259 250 58 1.6k
Yumiko Kagawa Japan 24 566 0.8× 429 0.8× 434 1.0× 248 1.0× 776 3.1× 138 2.0k
John P. Donahue United States 23 806 1.2× 426 0.8× 229 0.5× 233 0.9× 98 0.4× 50 1.9k
Kui Yang China 27 935 1.3× 327 0.6× 430 1.0× 234 0.9× 186 0.7× 77 1.9k
Takeshi Sato Japan 22 304 0.4× 323 0.6× 219 0.5× 176 0.7× 99 0.4× 83 1.3k
Arnoud H. de Ru Netherlands 29 950 1.4× 1.1k 2.0× 465 1.0× 374 1.4× 34 0.1× 86 2.4k
António Peixoto France 18 419 0.6× 783 1.4× 154 0.3× 80 0.3× 65 0.3× 27 1.4k
Ping Tsui United States 23 902 1.3× 364 0.7× 169 0.4× 314 1.2× 250 1.0× 53 1.8k
Thierry Chardès France 28 720 1.0× 524 1.0× 499 1.1× 122 0.5× 117 0.5× 71 2.0k
Ryuichiro Suto Japan 8 1.5k 2.1× 1.4k 2.5× 229 0.5× 108 0.4× 108 0.4× 26 2.4k
Helen P. Price United Kingdom 21 738 1.1× 430 0.8× 269 0.6× 105 0.4× 66 0.3× 60 2.2k

Countries citing papers authored by Michael Heike

Since Specialization
Citations

This map shows the geographic impact of Michael Heike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Heike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Heike more than expected).

Fields of papers citing papers by Michael Heike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Heike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Heike. The network helps show where Michael Heike may publish in the future.

Co-authorship network of co-authors of Michael Heike

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Heike. A scholar is included among the top collaborators of Michael Heike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Heike. Michael Heike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heike, Michael, et al.. (2012). Talgdrüsenheterotopie im Ösophagus. Der Pathologe. 34(2). 162–164. 4 indexed citations
2.
Fähndrich, M, M Sandmann, & Michael Heike. (2011). A new method for placement of covered colorectal stents in the proximal colon using double balloon enteroscopy. Endoscopy. 43(S 02). E23–E23. 1 indexed citations
3.
Fähndrich, M, M Sandmann, & Michael Heike. (2011). Removal of Over the Scope Clips (OTSC) with an Nd:YAG Laser. Zeitschrift für Gastroenterologie. 49(5). 579–583. 22 indexed citations
4.
Sandmann, M, M Fähndrich, J. Lorenzen, & Michael Heike. (2010). Gangliozytisches Paragangliom – eine seltene Ursache für eine obere gastrointestinale Blutung. Zeitschrift für Gastroenterologie. 48(11). 1297–1300. 4 indexed citations
5.
Sandmann, M, M Fähndrich, & Michael Heike. (2007). Pankreatikomediastinale Fistel als seltene Ursache rezidivierender Pleuraergüsse. Zeitschrift für Gastroenterologie. 45(10). 1056–1059.
6.
Hochhaus, Andreas, et al.. (2005). Phase I study of gefitinib in combination with FOLFIRI as 2nd-/3rd-line treatment in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3674–3674. 6 indexed citations
8.
Moehler, Markus, Juergen Siebler, Thomas Hoehler, et al.. (2004). CPT11/FA/5-FU versus ELF in chemonaive patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: A randomized phase II study. Journal of Clinical Oncology. 22(14_suppl). 4064–4064. 1 indexed citations
9.
Staib, Frank, et al.. (2004). Cross-presentation of human melanoma peptide antigen MART-1 to CTLs from in vitro reconstituted gp96/MART-1 complexes.. PubMed. 4. 3–3. 8 indexed citations
10.
Teufel, Andreas, Jürgen Siebler, Herbert Hohl, et al.. (2004). Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer. BMC Cancer. 4(1). 38–38. 30 indexed citations
11.
Moehler, Markus, Juergen Siebler, C Schimanski, et al.. (2003). Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer. Anti-Cancer Drugs. 14(8). 645–650. 16 indexed citations
12.
Staib, Frank, et al.. (2002). Different Efficiency of Heat Shock Proteins (HSP) to Activate Human Monocytes and Dendritic Cells: Superiority of HSP60. The Journal of Immunology. 169(11). 6141–6148. 129 indexed citations
14.
Heike, Michael, Christian Frenzel, D. Meier, & Peter R. Galle. (2000). Expression of stress protein gp96, a tumor rejection antigen, in human colorectal cancer. International Journal of Cancer. 86(4). 489–493. 24 indexed citations
15.
Heike, Michael, et al.. (1996). Impaired HLA-class-I stability in a sarcoma cell line which stimulates exclusively HLA-class-II-restricted autologous T cells. International Journal of Cancer. 67(5). 743–748. 1 indexed citations
17.
Bernhard, H., Gudrun Bernhard, Michael Heike, et al.. (1995). Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial. British Journal of Cancer. 71(1). 102–105. 33 indexed citations
18.
Heike, Michael, et al.. (1995). New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 426(4). 375–84. 8 indexed citations
19.
Herr, Wolfgang, et al.. (1994). Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells. Cancer Immunology Immunotherapy. 39(2). 93–99. 30 indexed citations
20.
Herr, Wolfgang, et al.. (1994). Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells. Cancer Immunology Immunotherapy. 39(2). 93–99. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026